Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 13:10:04 GMT 2023
by
admin
on
Sat Dec 16 13:10:04 GMT 2023
|
Protein Sub Type | |
Record UNII |
662XT84BPG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
662XT84BPG
Created by
admin on Sat Dec 16 13:10:05 GMT 2023 , Edited by admin on Sat Dec 16 13:10:05 GMT 2023
|
PRIMARY | |||
|
P06734
Created by
admin on Sat Dec 16 13:10:05 GMT 2023 , Edited by admin on Sat Dec 16 13:10:05 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_160 | 1_288 |
1_163 | 1_174 |
1_191 | 1_282 |
1_259 | 1_273 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_63 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INHIBITOR -> TARGET |
Kd; Predominant MOA is apoptotic cell death via the
intrinsic mitochondrial pathway
Ki
|
||
|
INHIBITOR -> TARGET |
MEDI4212 is directed against IgE, effectively blocking FcεRI and CD23, and thereby preventing an IgE-mediated response.
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|